157 related articles for article (PubMed ID: 33053272)
1. miRNAs and radiotherapy response in prostate cancer.
Konoshenko MY; Bryzgunova OE; Laktionov PP
Andrology; 2021 Mar; 9(2):529-545. PubMed ID: 33053272
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-guided gene expression in prostate cancer: Literature and database overview.
Bryzgunova OE; Konoshenko MY; Laktionov PP
J Gene Med; 2018 May; 20(5):e3016. PubMed ID: 29578262
[TBL] [Abstract][Full Text] [Related]
3. MiRNAs and radical prostatectomy: Current data, bioinformatic analysis and utility as predictors of tumour relapse.
Konoshenko MY; Laktionov PP
Andrology; 2021 Jul; 9(4):1092-1107. PubMed ID: 33638886
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?
Konoshenko M; Laktionov P; Bryzgunova O
Andrology; 2024 May; 12(4):705-718. PubMed ID: 37750354
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in Prostate Cancer Following Radiotherapy: Towards Predicting Response to Radiation Treatment.
Petrović N; Stanojković TP; Nikitović M
Curr Med Chem; 2022; 29(9):1543-1560. PubMed ID: 34348602
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.
Zhang W; Zang J; Jing X; Sun Z; Yan W; Yang D; Shen B; Guo F
J Transl Med; 2014 Mar; 12():66. PubMed ID: 24618011
[TBL] [Abstract][Full Text] [Related]
8. The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors.
Konoshenko M; Laktionov P
Andrology; 2022 Jan; 10(1):51-71. PubMed ID: 34333834
[TBL] [Abstract][Full Text] [Related]
9. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
[TBL] [Abstract][Full Text] [Related]
10. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
Foj L; Filella X
Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
Kumar B; Lupold SE
Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
[TBL] [Abstract][Full Text] [Related]
13. miRNAs as biomarkers in prostate cancer.
Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations.
Zedan AH; Blavnsfeldt SG; Hansen TF; Nielsen BS; Marcussen N; Pleckaitis M; Osther PJS; Sørensen FB
PLoS One; 2017; 12(6):e0179113. PubMed ID: 28628624
[TBL] [Abstract][Full Text] [Related]
15. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
16. Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study.
Alshalalfa M; Bader GD; Goldenberg A; Morris Q; Alhajj R
BMC Syst Biol; 2012 Aug; 6():112. PubMed ID: 22929553
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in prostate cancer: Functional role as biomarkers.
Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
[TBL] [Abstract][Full Text] [Related]
18. Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data.
Sun Y; Jia X; Hou L; Liu X
Urology; 2016 Aug; 94():313.e1-6. PubMed ID: 27179774
[TBL] [Abstract][Full Text] [Related]
19. Coordinate microRNA-mediated regulation of protein complexes in prostate cancer.
Alshalalfa M; Bader GD; Bismar TA; Alhajj R
PLoS One; 2013; 8(12):e84261. PubMed ID: 24391925
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA in prostate cancer: Practical aspects.
Patil PA; Magi-Galluzzi C
Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
